M. D. Gundersen

Repeated intensified infliximab induction – results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm

E. Paulssen, J. Florholmen, R. Goll, 2017, European journal of gastroenterology & hepatology.

Hypo-osmotic stress induces the epithelial alarmin IL-33 in the colonic barrier of ulcerative colitis

K. B. Larsen, G. Haraldsen, J. Florholmen, 2022, Scientific reports.

Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis

O. Sundnes, G. Haraldsen, J. Florholmen, 2016, Scientific Reports.

Discovery and validation of mucosal TNF expression combined with histological score - a biomarker for personalized treatment in ulcerative colitis

J. Florholmen, R. Goll, J. Kvamme, 2020, BMC Gastroenterology.

Mucosal gene transcription of ulcerative colitis in endoscopic remission

E. Anderssen, C. Fenton, J. Florholmen, 2020, Scandinavian journal of gastroenterology.

Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis.

E. Paulssen, J. Florholmen, R. Goll, 2016, Cytokine.